Pdt Partners, LLC Moderna, Inc. Transaction History

Pdt Partners, LLC

$1.02 Billion
Q3 2024

A detailed history of Pdt Partners, LLC transactions in Moderna, Inc. stock. As of the latest transaction made, Pdt Partners, LLC holds 21,300 shares of MRNA stock, worth $857,751. This represents 0.14% of its overall portfolio holdings.

Number of Shares

21,300

Previous 39,690 46.33%

Holding current value

$857,751

Previous $4.71 Million 69.81%

% of portfolio

0.14%

Previous 0.48%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$63.64 - $125.14 $1.17 Million - $2.3 Million	-18,390 Reduced 46.33%	21,300 $1.42 Million
Q2 2024 Aug 15, 2024	BUY	$101.21 - $166.61 $403,726 - $664,607	3,989 Added 11.17%	39,690 $4.71 Million
Q1 2024 May 15, 2024	SELL	$85.37 - $115.44 $127,969 - $173,044	-1,499 Reduced 4.03%	35,701 $3.8 Million
Q4 2023 Feb 14, 2024	BUY	$69.51 - $104.43 $1.77 Million - $2.66 Million	25,490 Added 217.68%	37,200 $3.7 Million
Q3 2023 Nov 14, 2023	BUY	$96.41 - $126.61 $1.13 Million - $1.48 Million	11,710 New	11,710 $1.21 Million
Q4 2021 Feb 14, 2022	SELL	$225.82 - $368.51 $431,316 - $703,854	-1,910 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$221.9 - $484.47 $423,829 - $925,337	1,910 New	1,910 $735,000
Q3 2020 Nov 16, 2020	SELL	$54.34 - $94.85 $666,371 - $1.16 Million	-12,263 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$29.67 - $80.0 $580,730 - $1.57 Million	-19,573 Reduced 61.48%	12,263 $787,000
Q1 2020 May 15, 2020	SELL	$17.78 - $31.58 $134,078 - $238,144	-7,541 Reduced 19.15%	31,836 $953,000
Q4 2019 Feb 14, 2020	BUY	$13.93 - $21.28 $548,521 - $837,942	39,377 New	39,377 $770,000

Others Institutions Holding MRNA

# of Institutions

953

Shares Held

240M

Call Options Held

10.6M

Put Options Held

18.7M

View Full List

About Moderna, Inc.

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $15.8B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

More about MRNA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pdt Partners, LLC with notifications on news.

Account